Literature DB >> 22895625

Superiority of conventional intensity-modulated radiotherapy over helical tomotherapy in locally advanced non-small cell lung cancer. A comparative plan analysis.

C Song1, H Pyo, J Kim, Y K Lim, W C Kim, H J Kim, D W Kim, K H Cho.   

Abstract

PURPOSE: To compare helical tomotherapy (HT) and conventional intensity-modulated radiotherapy (IMRT) using a variety of dosimetric and radiobiologic indexes in patients with locally advanced non-small cell lung cancer (LA-NSCLC). PATIENTS AND METHODS: A total of 20 patients with LA-NSCLC were enrolled. IMRT plans with 4-6 coplanar beams and HT plans were generated for each patient. Dose distributions and dosimetric indexes for the tumors and critical structures were computed for both plans and compared.
RESULTS: Both modalities created highly conformal plans. They did not differ in the volumes of lung exposed to > 20 Gy of radiation. The average mean lung dose, volume receiving ≥ 30 Gy, and volume receiving ≥ 10 Gy in HT planning were 18.3 Gy, 18.5%, and 57.1%, respectively, compared to 19.4 Gy, 25.4%, and 48.9%, respectively, with IMRT (p = 0.004, p < 0.001, and p < 0.001). The differences between HT and IMRT in lung volume receiving ≥ 10-20 Gy increased significantly as the planning target volume (PTV) increased. For 6 patients who had PTV greater than 700 cm(3), IMRT was superior to HT for 5 patients in terms of lung volume receiving ≥ 5-20 Gy. The integral dose to the entire thorax in HT plans was significantly higher than in IMRT plans.
CONCLUSION: HT gave significantly better control of mean lung dose and volume receiving ≥ 30-40 Gy, whereas IMRT provided better control of the lung volume receiving ≥ 5-15 Gy and the integral dose to entire thorax. In most patients with PTV greater than 700 cm(3), IMRT was superior to HT in terms of lung volume receiving ≥ 5-20 Gy. It is therefore advised that caution should be exercised when planning LA-NSCLC using HT.

Entities:  

Mesh:

Year:  2012        PMID: 22895625     DOI: 10.1007/s00066-012-0159-3

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  31 in total

Review 1.  Partial irradiation of the heart.

Authors:  G Gagliardi; I Lax; L E Rutqvist
Journal:  Semin Radiat Oncol       Date:  2001-07       Impact factor: 5.934

2.  Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study.

Authors:  Ellen D Yorke; Andrew Jackson; Kenneth E Rosenzweig; Louise Braban; Steven A Leibel; C Clifton Ling
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-06-04       Impact factor: 7.038

3.  Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method.

Authors:  G J Kutcher; C Burman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-06       Impact factor: 7.038

4.  Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy.

Authors:  T R Mackie; T Holmes; S Swerdloff; P Reckwerdt; J O Deasy; J Yang; B Paliwal; T Kinsella
Journal:  Med Phys       Date:  1993 Nov-Dec       Impact factor: 4.071

5.  Treatment-related pneumonitis and acute esophagitis in non-small-cell lung cancer patients treated with chemotherapy and helical tomotherapy.

Authors:  Chang Hoon Song; Hongryull Pyo; Sung Ho Moon; Tae Hyun Kim; Dae Woong Kim; Kwan Ho Cho
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-06       Impact factor: 7.038

6.  Treatment planning comparison between conformal radiotherapy and helical tomotherapy in the case of locally advanced-stage NSCLC.

Authors:  Giovanni Mauro Cattaneo; Italo Dell'oca; Sara Broggi; Claudio Fiorino; Lucia Perna; Marcella Pasetti; Giulia Sangalli; Nadia di Muzio; Ferruccio Fazio; Riccardo Calandrino
Journal:  Radiother Oncol       Date:  2008-08-07       Impact factor: 6.280

7.  Surface dose in the treatment of breast cancer with helical tomotherapy.

Authors:  Felix Zibold; Florian Sterzing; Gabriele Sroka-Perez; Kai Schubert; Katja Wagenknecht; Gerald Major; Jürgen Debus; Klaus Herfarth
Journal:  Strahlenther Onkol       Date:  2009-09-12       Impact factor: 3.621

8.  Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer.

Authors:  Ramesh Rengan; Kenneth E Rosenzweig; Ennapadam Venkatraman; Lawrence A Koutcher; Jana L Fox; Reena Nayak; Howard Amols; Ellen Yorke; Andrew Jackson; C Clifton Ling; Steven A Leibel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-11-01       Impact factor: 7.038

9.  Cancer risks attributable to low doses of ionizing radiation: assessing what we really know.

Authors:  David J Brenner; Richard Doll; Dudley T Goodhead; Eric J Hall; Charles E Land; John B Little; Jay H Lubin; Dale L Preston; R Julian Preston; Jerome S Puskin; Elaine Ron; Rainer K Sachs; Jonathan M Samet; Richard B Setlow; Marco Zaider
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-10       Impact factor: 11.205

10.  Helical tomotherapy. Experiences of the first 150 patients in Heidelberg.

Authors:  Florian Sterzing; Kai Schubert; Gabriele Sroka-Perez; Jörn Kalz; Jürgen Debus; Klaus Herfarth
Journal:  Strahlenther Onkol       Date:  2008-01       Impact factor: 3.621

View more
  5 in total

1.  Postoperative radiotherapy of patients with thymic epithelial tumors (TET): a retrospective analysis of outcome and toxicity.

Authors:  Matthias Felix Häfner; Falk Roeder; Florian Sterzing; David Krug; Stefan A Koerber; Jutta Kappes; Hans Hoffmann; Alla Slynko; Jürgen Debus; Marc Bischof
Journal:  Strahlenther Onkol       Date:  2014-08-26       Impact factor: 3.621

2.  DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)--a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume.

Authors:  Karl Wurstbauer; Heinz Deutschmann; Karin Dagn; Peter Kopp; Franz Zehentmayr; Bernd Lamprecht; Peter Porsch; Birgit Wegleitner; Michael Studnicka; Felix Sedlmayer
Journal:  Radiat Oncol       Date:  2013-03-05       Impact factor: 3.481

3.  Risk of radiation-induced pneumonitis after helical and static-port tomotherapy in lung cancer patients and experimental rats.

Authors:  Xianglan Zhang; You Keun Shin; Zhenlong Zheng; Lianhua Zhu; Ik Jae Lee
Journal:  Radiat Oncol       Date:  2015-09-17       Impact factor: 3.481

4.  Normal lung sparing Tomotherapy technique in stage III lung cancer.

Authors:  Chae-Seon Hong; Sang Gyu Ju; Yong Chan Ahn; Gyu Sang Yoo; Jae Myoung Noh; Dongryul Oh; Kwangzoo Chung; Hongryull Pyo; Kwanghyun Jo
Journal:  Radiat Oncol       Date:  2017-11-06       Impact factor: 3.481

5.  Is clinical target volume necessary?-a failure pattern analysis in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy using intensity-modulated radiotherapy technique.

Authors:  Liqing Zou; Li Chu; Fan Xia; Lijun Zhou; Xi Yang; Jianjiao Ni; Junchao Chen; Zhengfei Zhu
Journal:  Transl Lung Cancer Res       Date:  2020-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.